...
首页> 外文期刊>BMC Surgery >Ureteral urothelial carcinoma with squamous cell carcinoma and sarcomatoid carcinoma differentiation: a case report
【24h】

Ureteral urothelial carcinoma with squamous cell carcinoma and sarcomatoid carcinoma differentiation: a case report

机译:输尿管尿路上皮癌,鳞状细胞癌和Sarcomatoid癌分化:案例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Upper urinary tract urothelial carcinoma (UTUC) with multiple pathological types is extremely rare in the clinic, but the recurrence rate and mortality these patients are high. At present, there is no standard treatment for such cases. We reported a case of ureteral urothelial carcinoma with squamous cell carcinoma and sarcomatoid carcinoma differentiation and rapid ileal metastasis and reviewed the literature related to different pathological types of upper urinary tract tumours to explore the diagnosis, treatment and prognosis characteristics of the disease, enhance our understanding of its clinical manifestations and history of evolution and provide guidance for avoiding missed diagnosis and misdiagnosis. There is no standard treatment for urinary malignant tumours with multiple pathological types; radical surgery is considered a suitable choice. Chemotherapy, targeted drug therapy and immunotherapy may be beneficial to the survival of patients. In short, these patients have a high risk of recurrence and metastasis and a poor prognosis.
机译:具有多种病理类型的上尿道尿路上皮癌(UTUC)在诊所非常罕见,但这些患者的复发率和死亡率都很高。目前,此类病例没有标准治疗。我们报告了一种带有鳞状细胞癌和Sarcomatoid癌细胞分化和快速肠道转移的输尿管尿路上皮癌的情况,并审查了与不同病理类型的上泌尿道肿瘤相关的文献,以探讨了疾病的诊断,治疗和预后特征,提升了我们的理解其临床表现和演化史并为避免错过诊断和误诊提供指导。没有多种病理类型的尿恶性肿瘤没有标准治疗;激进手术被认为是合适的选择。化疗,靶向药物治疗和免疫疗法可能对患者的存活有益。简而言之,这些患者的复发和转移风险很高,预后差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号